Home » Topics » BioWorld Science

BioWorld Science
RSS

LUBAC identified as a biomarker of prognosis and potential therapeutic target in lung cancer

Sep. 20, 2019

Melflufen plus dexamethasone show encouraging activity in advanced RRMM with EMD

Sep. 20, 2019

NfL as biomarker for early diagnosis of polyneuropathy in patients with hATTR amyloidosis

Sep. 20, 2019

Positive topline results presented from phase III study of contezolid in cSSTI

Sep. 20, 2019

PDS Biotechnology presents phase I data for its novel immunotherapy PDS-0101

Sep. 20, 2019

CinDome Pharma initiates phase II study of deuterated domperidone

Sep. 20, 2019

Researchers unveil the role of vasorin in angiogenesis and tumor progression in glioma

Sep. 20, 2019

Rare eye disease gives clues to peripheral neuropathy

Sep. 20, 2019

CAR relative CCR may offer targeting advantages

Sep. 20, 2019

Bone-deep stress

Sep. 20, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...